Cambridge Consultants Innovation Day 2012: Creating global adoption
•
1 like•307 views
If a product, especially a medical product, is to be truly successful in increasingly competitive markets, it needs to be accepted and adopted by regulators and users alike, being safe to use while delighting the target audience. The barriers are made increasingly more difficult if your product is going to achieve success on a global platform. In this talk we examine what is required to develop a product that takes account of the needs of multi-markets and the range of cultural and social issues you will encounter when creating a product that can achieve success in both Japan and New Jersey.
Recommended
More Related Content
Viewers also liked
More from Cambridge Consultants
More from Cambridge Consultants (20)
Recently uploaded
Recently uploaded (20)
Cambridge Consultants Innovation Day 2012: Creating global adoption
- 1. Creating Global Adoption Client: Innovation Day 2012 Melanie Turieo | Serge Roux Commercially Confidential 13 November 2012 INNOV12-P-055 v1.0
- 2. HELLO! I’M… Melanie Turieo Serge Roux Must be safe Must be portable Should be compact Should inspire cleanliness Should be 100% recyclable Should reduce waste Ms. Mr. WHAT Commercially Confidential 2 HOW 13 November 2012 INNOV12-P-055 v1.0
- 3. HOW DO YOU MAKE A PRODUCT FOR THIS CROWD… …AS WELL AS THIS CROWD ? Commercially Confidential 3 13 November 2012 INNOV12-P-055 v1.0
- 4. The context trap Commercially Confidential 4 13 November 2012 INNOV12-P-055 v1.0
- 5. The culture trap Commercially Confidential 5 13 November 2012 INNOV12-P-055 v1.0
- 6. The illustration trap Commercially Confidential 6 13 November 2012 INNOV12-P-055 v1.0
- 7. The market trap Commercially Confidential 7 13 November 2012 INNOV12-P-055 v1.0
- 8. R2R VARIABILITY (Region to Region) Commercially Confidential 8 13 November 2012 INNOV12-P-055 v1.0
- 9. THE TARGET USER CONNUNDRUM Commercially Confidential 9 13 November 2012 INNOV12-P-055 v1.0
- 10. VARIABILITY & IMPACT Commercially Confidential 10 13 November 2012 INNOV12-P-055 v1.0
- 11. VARIABILITY & IMPACT Commercially Confidential 11 13 November 2012 INNOV12-P-055 v1.0
- 12. VARIABILITY & IMPACT Commercially Confidential 12 13 November 2012 INNOV12-P-055 v1.0
- 13. VARIABILITY & IMPACT Commercially Confidential 13 13 November 2012 INNOV12-P-055 v1.0
- 14. Dealing with complexity ELIMINATE ALLOCATE EDUCATE Commercially Confidential 14 13 November 2012 INNOV12-P-055 v1.0
- 15. ELIMINATE Do not reinvent the wheel Commercially Confidential 15 13 November 2012 INNOV12-P-055 v1.0
- 16. ELIMINATE Eliminate failure modes Commercially Confidential 16 13 November 2012 INNOV12-P-055 v1.0
- 17. ELIMINATE Eliminate bespoke resources Commercially Confidential 17 13 November 2012 INNOV12-P-055 v1.0
- 18. ALLOCATE Absorb complexity into the device Commercially Confidential 18 13 November 2012 INNOV12-P-055 v1.0
- 19. ALLOCATE Assign complexity to the most agile component Commercially Confidential 19 13 November 2012 INNOV12-P-055 v1.0
- 20. EDUCATE Make the result apparent Commercially Confidential 20 13 November 2012 INNOV12-P-055 v1.0
- 21. EDUCATE Reinforce intended use Commercially Confidential 21 13 November 2012 INNOV12-P-055 v1.0
- 22. AS A RECAP… Stratify your MARKET wisely and understand VARIABILITY Build a HUMAN platform with an agile PERSONALITY Commercially Confidential 22 13 November 2012 INNOV12-P-055 v1.0
- 23. Thank you! Client: Innovation Day 2012 Melanie Turieo | Serge Roux Commercially Confidential 13 November 2012 INNOV12-P-055 v1.0